GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Merus NV (FRA:2GH) » Definitions » Cyclically Adjusted PB Ratio

Merus NV (FRA:2GH) Cyclically Adjusted PB Ratio : 10.92 (As of Jun. 10, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Merus NV Cyclically Adjusted PB Ratio?

As of today (2024-06-10), Merus NV's current share price is €48.80. Merus NV's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €4.47. Merus NV's Cyclically Adjusted PB Ratio for today is 10.92.

The historical rank and industry rank for Merus NV's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:2GH' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.93   Med: 8.95   Max: 11.93
Current: 10.53

During the past years, Merus NV's highest Cyclically Adjusted PB Ratio was 11.93. The lowest was 5.93. And the median was 8.95.

FRA:2GH's Cyclically Adjusted PB Ratio is ranked worse than
90.02% of 661 companies
in the Biotechnology industry
Industry Median: 1.67 vs FRA:2GH: 10.53

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Merus NV's adjusted book value per share data for the three months ended in Mar. 2024 was €5.478. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €4.47 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Merus NV Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Merus NV's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus NV Cyclically Adjusted PB Ratio Chart

Merus NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 5.72

Merus NV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 5.72 8.96

Competitive Comparison of Merus NV's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Merus NV's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merus NV's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Merus NV's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Merus NV's Cyclically Adjusted PB Ratio falls into.



Merus NV Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Merus NV's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=48.80/4.47
=10.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merus NV's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Merus NV's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.478/128.5800*128.5800
=5.478

Current CPI (Mar. 2024) = 128.5800.

Merus NV Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 99.240 0.000
201409 0.000 99.960 0.000
201412 -0.228 99.050 -0.296
201503 0.000 99.750 0.000
201506 -0.545 100.230 -0.699
201509 2.221 100.500 2.842
201512 1.995 99.730 2.572
201603 1.658 100.310 2.125
201606 4.209 100.260 5.398
201609 3.962 100.570 5.065
201612 2.109 100.710 2.693
201703 4.703 101.440 5.961
201706 3.819 101.370 4.844
201709 3.032 102.030 3.821
201712 2.953 101.970 3.724
201803 4.215 102.470 5.289
201806 4.061 103.100 5.065
201809 3.720 103.950 4.601
201812 3.983 103.970 4.926
201903 3.697 105.370 4.511
201906 3.302 105.840 4.011
201909 2.987 106.700 3.600
201912 4.091 106.800 4.925
202003 3.575 106.850 4.302
202006 3.066 107.510 3.667
202009 2.467 107.880 2.940
202012 2.660 107.850 3.171
202103 5.192 108.870 6.132
202106 4.730 109.670 5.546
202109 4.531 110.790 5.259
202112 6.438 114.010 7.261
202203 6.202 119.460 6.675
202206 6.736 119.050 7.275
202209 6.517 126.890 6.604
202212 5.036 124.940 5.183
202303 4.384 124.720 4.520
202306 4.766 125.830 4.870
202309 6.385 127.160 6.456
202312 5.651 126.450 5.746
202403 5.478 128.580 5.478

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Merus NV  (FRA:2GH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Merus NV Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Merus NV's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Merus NV (FRA:2GH) Business Description

Industry
Traded in Other Exchanges
Address
Uppsalalaan 17, Utrecht, NLD, 3584 CT
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Merus NV (FRA:2GH) Headlines

No Headlines